RENOVA, Inc.

TSE:9519.T

939 (JPY) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Revenue 15,15714,92111,2768,9559,5968,7807,4638,84012,3838,1157,7927,2876,1424,4125,6174,7925,9865,7684,8215,3123,5483,8663,3133,3433,012.6292,711.4433,535.3962,480.5321,490.9861,145.9872,8142,814
Cost of Revenue 11,99311,7528,2892,5772,9233,0272,5602,3102,0722,4952,3181,730508-5,8416075952,4732,4292,1132,1151,6601,6931,6661,5531,596.8541,717.8471,663.552801.747644.982687.3551,1691,169
Gross Profit 3,1643,1692,9876,3786,6735,7534,9036,53010,3115,6205,4745,5575,63410,2535,0104,1973,5133,3392,7083,1971,8882,1731,6471,7901,415.775993.5961,871.8441,678.785846.004458.6321,6451,645
Gross Profit Ratio 0.2090.2120.2650.7120.6950.6550.6570.7390.8330.6930.7030.7630.9172.3240.8920.8760.5870.5790.5620.6020.5320.5620.4970.5350.470.3660.5290.6770.5670.40.5850.585
Reseach & Development Expenses 00000000000000000000000000000000
General & Administrative Expenses 000000000000000003810000778717138000226000
Selling & Marketing Expenses 0000000000000000064900000056300037000
SG&A 3,0898858608568498428398458711,0289469358403,5951,2861,1971,0951,0301,073872954719778717701532501514529396415.5415.5
Other Expenses 0-3,471-1,7413504245,3044,2364,6914,2286,0825,3674,0343,27310,123-173-206-228-239-131-185-110-109-103-102-149.728-95.86-97.214-43.198-70.172-62.17600
Operating Expenses 3,0894,3562,6013,4493,4635,3044,2364,6914,2286,0825,3674,0343,27310,1233,1873,1311,0951,0791,073872954719778717731.253532.433500.437514.877573.181396.086412412
Operating Income 75-1,1873863,2452,9885439011,3176,10944-3,0211,5332,483-1611,7111,0012,4182,2611,6342,3249341,4548691,072682.522461.1631,371.4081,163.907272.82262.5481,229.51,229.5
Operating Income Ratio 0.005-0.080.0340.3620.3110.0620.1210.1490.4930.005-0.3880.210.404-0.0360.3050.2090.4040.3920.3390.4380.2630.3760.2620.3210.2270.170.3880.4690.1830.0550.4370.437
Total Other Income Expenses Net -2284,2963,438-539-348-2,434-675-492-440-902-3,2935,385-342-8712,314-841-744-75647069-336-451-350-431-393.212-423.991-437.275-304.522-359.818-200.975568568
Income Before Tax -1533,1093,8242,7062,640-1,8912268255,669-858-3,1866,9182,14110,3884,0255261,6741,5052,1042,3935981,003519641289.3137.172934.133859.385-86.996-138.4271,797.51,797.5
Income Before Tax Ratio -0.010.2080.3390.3020.275-0.2150.030.0930.458-0.106-0.4090.9490.3492.3540.7170.110.280.2610.4360.450.1690.2590.1570.1920.0960.0140.2640.346-0.058-0.1210.6390.639
Income Tax Expense -142174-38632728-397367288568-4941,321545636701,251143580401581659219290138188-124.528153.783237.363220.382-222.9453.288548.5548.5
Net Income 3312,8733,1661,4641,354-1,494-1415374,637-364-5,1125,9261,31010,6632,5932116788831,3161,35611951581241189.36-289.441429.012471.06921.19-221.4411,111.51,111.5
Net Income Ratio 0.0220.1930.2810.1630.141-0.17-0.0190.0610.374-0.045-0.6560.8130.2132.4170.4620.0440.1130.1530.2730.2550.0340.1330.0240.0720.063-0.1070.1210.190.014-0.1930.3950.395
EPS 3.7336.3940.1318.5617.2-18.99-1.796.8459.04-4.66-65.475.9716.85137.0733.722.7514.2711.5517.2118.021.599.485.133.255.57-3.949.486.411.85-3.1515.8515.85
EPS Diluted 3.7336.314018.517.14-18.99-1.796.7958.61-4.66-65.474.8516.55137.0732.872.6813.8811.5517.2118.021.529.485.133.065.57-3.99.486.131.85-3.0115.8515.85
EBITDA 4,1412,4973,2125,7375,5792,8513,2913,7398,6352,452-5693,5594,04412,7703,5852,5143,6752,0101,4902,1347011,327766968529.271367.1571,273.5521,149.02226.744256.783430.5430.5
EBITDA Ratio 0.2730.1670.2850.6410.5810.3250.4410.4230.6970.302-0.0730.4880.6582.8940.6380.5250.6140.3480.3090.4020.1980.3430.2310.290.1760.1350.360.4630.1520.2240.1530.153